PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds
Status:
Terminated
Trial end date:
2020-08-30
Target enrollment:
Participant gender:
Summary
To treat Pakistani patients with non-life threatening symptomatic SARS-CoV-2 infection with
an intent to reduce burden on institutional healthcare services by determining efficacy of
different chloroquine and hydroxychloroquine dosing regimens in controlling SARS-CoV-2
infection.
Phase:
Phase 4
Details
Lead Sponsor:
Government of Punjab, Specialized Healthcare and Medical Education Department
Collaborators:
Mayo Hospital Lahore Pakistan Kidney and Liver Institute Services Hospital, Lahore